-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hemorrhage_2-team-structure.pptx
July 01, 2023 - People resist loss not change
Try to surface and mitigate real AND perceived loss
Physician’s time is … As you do so, it is helpful to remember a few pointers:
People resist loss, not change. … The loss can be real or perceived. … Communication is key, especially when perceived loss is high. … The only way to help staff feel more comfortable with change (and perceived loss) is to talk about it
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hypertension_2-team-structure-speaker-notes.pdf
July 01, 2023 - • People resist loss not change
• Try to surface and mitigate real AND perceived loss
o Physician’ … s time is likely a major concern
• Perceived losses often much greater than real
• Perceived loss … As you do so, it is helpful to remember a few pointers:
• People resist loss, not change. … • The loss can be real or perceived. … • Communication is key, especially when perceived loss is high.
-
ce.effectivehealthcare.ahrq.gov/sites/default/files/wysiwyg/hai/tools/perinatal-care-2/hypertension_2-team-structure.pptx
July 01, 2023 - People resist loss not change
Try to surface and mitigate real AND perceived loss
Physician’s time is … As you do so, it is helpful to remember a few pointers:
People resist loss, not change. … The loss can be real or perceived. … Communication is key, especially when perceived loss is high. … The only way to help staff feel more comfortable with change (and perceived loss) is to talk about it
-
psnet.ahrq.gov/sites/default/files/import/webmm.ahrq.gov.230_slideshow.ppt
December 01, 2010 - Stage II Partial thickness loss of dermis presenting as a shallow open ulcer with a red pink wound bed … Stage III Full thickness tissue loss. … Slough may be present but does not obscure the depth of tissue loss. … Stage IV Full thickness tissue loss with exposed bone, tendon or muscle. … Unstageable Full thickness tissue loss in which the base of the ulcer is covered by slough (yellow, tan
-
effectivehealthcare.ahrq.gov/products/glaucoma-screening/research-protocol
November 16, 2010 - million people worldwide by 2010. 1,2 Glaucoma may be classified by optic nerve damage, visual field loss … tandem to confirm diagnosis. 3 Damage is irreversible, so early detection may prevent severe vision loss … CER:
The USPSTF noted that studies of frequency-doubling technology, used to assess visual field loss … as well as the impact of functional loss on activities of daily living ( Primary outcome ). … The proportion of participants with progression of visual field loss as defined by included studies
-
www.uspreventiveservicestaskforce.org/uspstf/recommendation/postmenopausal-osteoporosis-screening-1996
January 01, 1996 - 2.5 SD below the normal mean. 13 Risk of postmenopausal osteoporosis is a function of rate of bone loss … of bone turnover, which may be able to identify those women who will develop more significant bone loss … Because the rate of postmenopausal bone loss varies among women, bone mass at menopause correlates only … Prediction of rapid bone loss in postmenopausal women. Lancet . 1987;1:1105–1108. [PubMed] 4. … Role of peak bone mass and bone loss in postmenopausal osteoporosis.
-
ce.effectivehealthcare.ahrq.gov/hai/cusp/toolkit/content-calls/phys-engagement/slides.html
June 01, 2013 - People resist loss, not change
Try to surface and mitigate real and perceived loss
Physician’s time … is likely a major concern
Perceived losses often much greater than real loss
Perceived loss high … communication
Develop communication plan for CUSP education
Listen to physicians to surface and mitigate loss
-
preventiveservices.ahrq.gov/hai/cusp/toolkit/content-calls/phys-engagement/slides.html
June 01, 2013 - People resist loss, not change
Try to surface and mitigate real and perceived loss
Physician’s time … is likely a major concern
Perceived losses often much greater than real loss
Perceived loss high … communication
Develop communication plan for CUSP education
Listen to physicians to surface and mitigate loss
-
effectivehealthcare.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
November 16, 2010 - million
people worldwide by 2010.1,2 Glaucoma may be classified by optic nerve damage, visual field loss … tandem to confirm diagnosis.3
Damage is irreversible, so early detection may prevent severe vision loss … • The USPSTF noted that studies of frequency-doubling technology, used to assess visual field loss … loss on activities of daily living (Primary outcome). … The proportion of participants with progression of visual field loss as defined by included
studies
-
effectivehealthcare-admin.ahrq.gov/sites/default/files/pdf/glaucoma-screening_research-protocol.pdf
November 16, 2010 - million
people worldwide by 2010.1,2 Glaucoma may be classified by optic nerve damage, visual field loss … tandem to confirm diagnosis.3
Damage is irreversible, so early detection may prevent severe vision loss … • The USPSTF noted that studies of frequency-doubling technology, used to assess visual field loss … loss on activities of daily living (Primary outcome). … The proportion of participants with progression of visual field loss as defined by included
studies
-
srdr.ahrq.gov/projects/1705/studies/197199
January 01, 2018 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197186
January 01, 1999 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197200
January 01, 1994 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197197
January 01, 2005 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197187
January 01, 2007 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197190
January 01, 2013 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197204
January 01, 2005 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197212
January 01, 2014 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197184
January 01, 2009 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss
-
srdr.ahrq.gov/projects/1705/studies/197202
January 01, 2003 - including virologic or histologic improvement, clearance of hepatitis B e-antigen (HBeAg) (as indicated by loss … antibody to HBeAg [anti-HBe]), or clearance of hepatitis B surface antigen (HBsAg) (as indicated by loss